| 08/24/2026 7:03 PM | Chernett Jorey (2042077) Filed by Neuronetics (1227636) Subject | Form SCHEDULE 13D/A | |
| 08/19/2026 1:13 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/18/2026 3:46 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/17/2026 3:10 PM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/17/2026 9:13 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/11/2026 4:27 PM | Neuronetics (1227636) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 08/11/2026 7:05 AM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/04/2026 7:00 AM | Chernett Jorey (2042077) Filed by Neuronetics (1227636) Subject | Form SCHEDULE 13D/A | |
| 07/20/2026 3:10 PM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/15/2026 8:33 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/13/2026 3:15 PM | Anderson Cory (2143826) Reporting Neuronetics (1227636) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for STIM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Neuronetics and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/23/2026 3:38 PM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/17/2026 3:57 PM | Amin Avinash (2044406) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/17/2026 3:47 PM | Madryn Asset Management, LP (1787423) Reporting MADRYN HEALTH ADVISORS GP II, LLC (2007801) Reporting MADRYN HEALTH ADVISORS II, LP (2007977) Reporting MADRYN HEALTH PARTNERS II (0) CAYMAN MASTER Madryn Health Partners II, LP (1919858) Reporting Madryn Select Opportunities, LP (1889283) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:38 PM | Neuronetics (1227636) Subject Sullivan Keith J (1417973) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/29/2026 4:28 PM | Neuronetics (1227636) Filer | Form SD Specialized Disclosure Report | |
| 05/29/2026 4:10 PM | Neuronetics (1227636) Issuer Rosengarten Megan (1876577) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 3:59 PM | Amin Avinash (2044406) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:01 PM | CASCELLA ROBERT (1218713) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:02 PM | CONLEY SHERYL L (1238659) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:04 PM | Cucuz Sasha (2004858) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 4:05 PM | MUIR GLENN P (1181190) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/29/2026 3:45 PM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/27/2026 9:33 AM | Chernett Jorey (2042077) Filed by Neuronetics (1227636) Subject | Form SCHEDULE 13D/A | |
| 05/22/2026 6:30 AM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/21/2026 3:05 PM | Neuronetics (1227636) Issuer Pfanstiel Steven (1856059) Reporting | Form 4/A | |
| 05/20/2026 11:39 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 7:31 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/05/2026 8:10 AM | Neuronetics (1227636) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/05/2026 7:04 AM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/22/2026 8:39 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/12/2026 11:15 PM | Neuronetics (1227636) Filer | Form EFFECT | |
| 04/09/2026 3:02 PM | Neuronetics (1227636) Filer | Form DEF 14A | |
| 04/09/2026 3:05 PM | Neuronetics (1227636) Filer | Form DEFA14A | |
| 04/08/2026 8:17 AM | Chernett Jorey (2042077) Filed by Neuronetics (1227636) Subject | Form SCHEDULE 13D/A | |
| 04/06/2026 3:40 PM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/01/2026 3:57 PM | Madryn Asset Management, LP (1787423) Reporting MADRYN HEALTH ADVISORS GP II, LLC (2007801) Reporting MADRYN HEALTH ADVISORS II, LP (2007977) Reporting MADRYN HEALTH PARTNERS II (0) CAYMAN MASTER Madryn Health Partners II, LP (1919858) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/30/2026 6:41 PM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/30/2026 8:37 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 8:33 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 4:52 PM | Neuronetics (1227636) Issuer Pfanstiel Steven (1856059) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
How to get a stake in Anthropic — before the IPO (Ad) Anthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its valuation has doubled since the announcement, with some estimates putting the company's worth near 3 trillion dollars by IPO day.
Google, Amazon, Nvidia and Microsoft have all taken stakes, while Goldman Sachs, Morgan Stanley and JPMorgan are competing for private shares. Anthropic's annualized revenue reportedly grew 80 times in the first quarter alone.
See how investors are positioning ahead of this closely watched IPO. Learn how to get a stake before the Anthropic IPO |
| 03/24/2026 4:48 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/24/2026 4:50 PM | Neuronetics (1227636) Issuer Sullivan Keith J (1417973) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 3:38 PM | Neuronetics (1227636) Issuer REUVERS DANIEL L. (1563602) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/23/2026 3:41 PM | Neuronetics (1227636) Issuer REUVERS DANIEL L. (1563602) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 8:34 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 7:51 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/19/2026 3:36 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/18/2026 9:36 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 9:31 AM | Chernett Jorey (2042077) Reporting Neuronetics (1227636) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 8:20 AM | Chernett Jorey (2042077) Filed by Neuronetics (1227636) Subject | Form SCHEDULE 13G/A | |
| 03/17/2026 12:09 PM | Neuronetics (1227636) Subject Parian Ultreia LP (2075833) Filed by | Form SCHEDULE 13G | |
| 03/17/2026 6:55 AM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/17/2026 7:00 AM | Neuronetics (1227636) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/06/2026 3:29 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 4:33 PM | Madryn Asset Management, LP (1787423) Filed by Neuronetics (1227636) Subject | Form SCHEDULE 13D/A | |
| 03/04/2026 2:09 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 3:30 PM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/26/2026 2:16 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/26/2026 2:33 PM | Neuronetics (1227636) Subject Sullivan Keith J (1417973) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/25/2026 3:45 PM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/25/2026 3:30 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/25/2026 3:30 PM | Neuronetics (1227636) Issuer Pfanstiel Steven (1856059) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/18/2026 4:42 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/18/2026 4:44 PM | Neuronetics (1227636) Issuer Sullivan Keith J (1417973) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/12/2026 2:12 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/12/2026 2:19 PM | Neuronetics (1227636) Subject Sullivan Keith J (1417973) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/10/2026 3:14 PM | Neuronetics (1227636) Subject Sullivan Keith J (1417973) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/04/2026 1:29 PM | Chernett Jorey (2042077) Filed by Neuronetics (1227636) Subject | Form SCHEDULE 13G/A | |
| 01/22/2026 6:30 AM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/06/2026 4:00 PM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/31/2025 4:05 PM | Neuronetics (1227636) Issuer Pfanstiel Steven (1856059) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/31/2025 4:05 PM | MACAN WILLIAM ANDREW (1758584) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 1:31 PM | Chernett Jorey (2042077) Filed by Neuronetics (1227636) Subject | Form SCHEDULE 13G | |
| 11/04/2025 6:31 AM | Neuronetics (1227636) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/04/2025 6:10 AM | Neuronetics (1227636) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/22/2025 3:45 PM | Cucuz Sasha (2004858) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 3:45 PM | MUIR GLENN P (1181190) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 3:45 PM | CONLEY SHERYL L (1238659) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 3:45 PM | CASCELLA ROBERT (1218713) Reporting Neuronetics (1227636) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |